Saxenda 6mg/ml

Price range: £68.00 through £260.00

Saxenda is a prescription injection pen containing liraglutide, used to support weight loss in overweight or obese adults.
GLP-1 agonist administered once daily.
Packaging and branding may differ from image shown.

Start Assessment

Description

Saxenda is a prescription weight loss injection pen that contains liraglutide, a medication from the GLP-1 receptor agonist family. It is designed to help manage chronic weight issues by mimicking a natural hormone that regulates appetite and calorie intake.

Saxenda is recommended for adults with a BMI of 30 or more, or a BMI of 27 or more with at least one weight-related health condition, such as high blood pressure, high cholesterol, or type 2 diabetes. It is used alongside a reduced-calorie diet and increased physical activity.

How It Works

Liraglutide mimics the action of glucagon-like peptide-1 (GLP-1), a hormone that targets brain receptors involved in appetite regulation. By activating these receptors, Saxenda helps suppress appetite, increase feelings of fullness, and reduce caloric intake.

Unlike stimulant-based weight loss drugs, Saxenda works through hormonal signalling and has no impact on the central nervous system, making it safer for long-term use in eligible patients.

Why Choose Saxenda

Clinically proven to support sustained weight loss

Once-daily injection with a pre-filled pen

Suitable for patients with obesity-related health risks

Helps improve blood glucose, cholesterol, and blood pressure

Aids in maintaining weight loss over time

Saxenda is often prescribed when diet and exercise alone haven’t produced significant results. It is part of a comprehensive weight management plan and is monitored by healthcare professionals.

Important Note

Do not exceed the maximum dose of 3.0 mg daily. Gradual dose increases reduce the chance of side effects. Monitor for signs of nausea, especially during the initial titration period.

Saxenda should be stored in the refrigerator before use. Once in use, it can be kept at room temperature for up to 30 days, but should be kept out of direct sunlight and not frozen.

Seek immediate medical attention if you experience severe abdominal pain, symptoms of pancreatitis, or signs of allergic reaction.

Directions

Note: Always follow your doctor’s instructions.

  • Starting dose: 0.6 mg once daily

  • Increase weekly by 0.6 mg until maintenance dose of 3.0 mg/day is reached

  • Administer subcutaneously in the abdomen, thigh, or upper arm

  • Use at the same time daily, with or without food

Storage:

  • Store unused pens in the refrigerator (2°C–8°C)

  • Once in use, keep at room temperature (below 30°C) for up to 30 days

  • Do not freeze or expose to heat/light

Ingredients

  • Active Ingredient:

    • Liraglutide 6 mg/ml in a 3ml pre-filled pen

  • Excipients:

    • Disodium phosphate dihydrate

    • Propylene glycol

    • Phenol

    • Water for injections

Side Effects

  • Common:

    • Nausea

    • Diarrhoea

    • Constipation

    • Headache

    • Injection site pain

    Serious:

    • Pancreatitis

    • Gallstones

    • Kidney problems

    • Suicidal thoughts (rare – monitor mood)

    Report any persistent or severe symptoms to your doctor.

Warnings

  • Not suitable for:

    • People with thyroid cancer history

    • Pregnant or breastfeeding individuals

    • Children or adolescents under 18

  • Use with caution if:

    • You have kidney, liver, or gallbladder issues

    • You’re taking insulin or sulfonylureas (risk of hypoglycaemia)

  • No. Saxenda should not be combined with other GLP-1 agonists or weight loss treatments unless specifically advised by your doctor.
  • Saxenda begins to reduce appetite and support weight loss within a few days to weeks, but noticeable results are typically seen after 4 to 8 weeks of continuous use.
  • No. Saxenda should not be used during pregnancy or while breastfeeding. Discuss alternative options with your doctor if applicable.
  • Yes, Saxenda can be used long-term under medical supervision. Treatment is usually reviewed after 16 weeks to assess effectiveness.
  • Saxenda is used to aid weight loss in adults who are overweight (BMI ≥27) with a weight-related condition (e.g. type 2 diabetes or hypertension), or obese (BMI ≥30).